LIPELLA PHARMACEUTICALS INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

LIPELLA PHARMACEUTICALS INC. reported Cash And Cash Equivalents At Carrying Value of $2.18 million for the year ending 2024.

  • LIPELLA PHARMACEUTICALS INC. showed a decrease of -33.7% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from LIPELLA PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), LIPELLA PHARMACEUTICALS INC.'s Cash And Cash Equivalents At Carrying Value has grown by 54.5%.
  • Historical annual values: Fiscal year 2024: $2.18 million | Fiscal year 2023: $3.29 million | Fiscal year 2022: $5.12 million | Fiscal year 2021: $1.41 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: